Sort
78,016 grants matching “breast cancer”
Biomarkers for predicting response to Hsp90 therapy
$573,509Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
Policy-relevant mechanisms of socioeconomic disparities in adherence to oral hormonal therapy for breast cancer
$573,471Joan Marie Neuner · Medical College Of Wisconsin · R01 · FY2018 · MD
Development of nanoscale infrared spectroscopic imaging for measuring cellular ultrastructure
$573,470Rohit Bhargava · University Of Illinois At Urbana-Champaign · R01 · FY2025 · CA
Evaluating an evidence-based family history screening program adapted to increase reach and uptake of screening for BRCA-associated cancers in rural public health clinics
$573,462Yue Guan · Emory University · R37 · FY2024 · CA
Risk Prediction for Breast Cancer: A Tissue-Based Strategy
$573,372Lynn C. Hartmann · Mayo Clinic Rochester · R01 · FY2011 · CA
HER2-targeting transformable nanotherapeutic platform against HER2+ cancers
$573,341Kit S Lam · University Of California At Davis · R01 · FY2020 · CA
Tumor-specific autoantibodies for SCLC early detection
$573,272A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2020 · CA
GigaFIBI; rapid, large-format histology-resolution imaging for Intraoperative assessment of breast lumpectomy margins
$573,241Farzad Fereidouni · Emory University · R01 · FY2025 · CA
A comprehensive approach to breast cancer susceptibility across the risk spectrum
$573,230David E. Goldgar · University Of Utah · R01 · FY2014 · CA
Systematic Identification of Driver Networks in Cancer
$573,223Nevan J Krogan · University Of California, San Francisco · U54 · FY2018 · CA
Simultaneous Emission and Transmission Mammotomography
$573,108Martin P Tornai · Duke University · R01 · FY2010 · CA
Efficacy of MBSR Treatment of Cognitive Impairment Among Breast Cancer Survivors
$573,107Cecile A Lengacher · University Of South Florida · R01 · FY2018 · CA
Lipid-based Nanocapsules and Triggered Chemotherapy
$573,107Robert Blumenthal · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
BRCA2 missense mutations and breast cancer
$573,091Fergus Joseph Couch · Mayo Clinic Rochester · R01 · FY2007 · CA
Combine mitochondrial gene therapy and synthetic lethal chemotherapy to treat triple-negative breast cancer
$573,078Xiaoguang Margaret Liu · Ohio State University · R01 · FY2025 · CA
"Statistical Methods for Genetic Epidemiology"
$573,074Alice S Whittemore · Stanford University · R01 · FY2009 · CA
Moving Forward: A weight loss program for African-American breast cancer survivo
$573,073Ben Steven Gerber · University Of Illinois At Chicago · R01 · FY2015 · CA
Credentialing Models of Invasive Lobular Breast Cancer for Translational Research
$573,041Steffi Oesterreich · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
High Deductible Insurance: Impact on Breast Cancer Care and Outcomes
$573,024James Franklin Wharam · Harvard Pilgrim Health Care, Inc. · R01 · FY2017 · CA
INTEGRATED MULTI-MODALITY, IMAGE BASED MARKERS OF BREAST DENSITY & STUCTURE IN ASSESSING BREAST CANCER RISK CANCER RISK AT THE UNIVERSITY OF CHICAGO
$573,000University Of Chicago · · FY2008 · Department of Energy
A comprehensive approach to breast cancer susceptibility across the risk spectrum
$572,952David E. Goldgar · University Of Utah · R01 · FY2011 · CA
DEFINING ABERRANT EPITHELIAL CELL POLARITY-REGULATED CUES IN BREAST CANCER
$572,950Trustees Of Boston University · · FY2014 · Department of Defense
REACH UP & OUT: Eliminating Breast and Cervical Cancer Disparities
$572,913Isabel C Scarinci · University Of Alabama At Birmingham · R24 · FY2010 · MD
CANCER AND LEUKEMIA GROUP B
$572,909Brigham And Women'S Hospital · U10 · FY2000 · CA
Modeling response to MAPK Inhibitors
$572,859Wolfgang Michael Korn · Oregon Health & Science University · U54 · FY2014 · CA